» Articles » PMID: 37674997

Extracorporeal Organ Support and the Kidney

Overview
Journal Front Nephrol
Specialty Nephrology
Date 2023 Sep 7
PMID 37674997
Authors
Affiliations
Soon will be listed here.
Abstract

The concept of extracorporeal organ support (ECOS) encompasses kidney, respiratory, cardiac and hepatic support. In an era of increasing incidence and survival of patients with single or multiple organ failure, knowledge on both multiorgan crosstalk and the physiopathological consequences of extracorporeal organ support have become increasingly important. Immerse within the cross-talk of multiple organ failure (MOF), Acute kidney injury (AKI) may be a part of the clinical presentation in patients undergoing ECOS, either as a concurrent clinical issue since the very start of ECOS or as a event at any point in the clinical course. At any point during the clinical course of a patient with single or multiple organ failure undergoing ECOS, renal function may improve or deteriorate, as a result of the interaction of multiple factors, including multiorgan crosstalk and physiological consequences of ECOS. Common physiopathological ways in which ECOS may influence renal function includes: 1) multiorgan crosstalk (preexisting or 2)Hemodynamic changes and 3) ECOS-associated coagulation abnormalities and 3) Also, cytokine profile switch, neurohumoral changes and toxins clearance may contribute to the expected physiological changes related to ECOS. The main objective of this review is to summarize the described mechanisms influencing the renal function during the course of ECOS, including renal replacement therapy, extracorporeal membrane oxygenation/carbon dioxide removal and albumin dialysis.

Citing Articles

Advancements in understanding the mechanisms of lung-kidney crosstalk.

Mendes R, Silva P, Robba C, Battaglini D, Lopes-Pacheco M, Caruso-Neves C Intensive Care Med Exp. 2024; 12(1):81.

PMID: 39298036 PMC: 11413270. DOI: 10.1186/s40635-024-00672-1.


Extracorporeal organ support for critically ill patients: Overcoming the past, achieving the maximum at present, and redefining the future.

Papamichalis P, Oikonomou K, Xanthoudaki M, Valsamaki A, Skoura A, Papathanasiou S World J Crit Care Med. 2024; 13(2):92458.

PMID: 38855267 PMC: 11155504. DOI: 10.5492/wjccm.v13.i2.92458.

References
1.
Karagiannidis C, Hesselmann F, Fan E . Physiological and Technical Considerations of Extracorporeal CO Removal. Crit Care. 2019; 23(1):75. PMC: 6408850. DOI: 10.1186/s13054-019-2367-z. View

2.
Yoo S, Ki M, Kim D, Kim S, Park S, Han H . Bleeding complications associated with the molecular adsorbent recirculating system: a retrospective study. Acute Crit Care. 2022; 36(4):322-331. PMC: 8907459. DOI: 10.4266/acc.2021.00276. View

3.
Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I . Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007; 33(9):1563-70. DOI: 10.1007/s00134-007-0754-4. View

4.
ONeil M, Fleming J, Badhwar A, Guo L . Pulsatile versus nonpulsatile flow during cardiopulmonary bypass: microcirculatory and systemic effects. Ann Thorac Surg. 2012; 94(6):2046-53. DOI: 10.1016/j.athoracsur.2012.05.065. View

5.
Braun D, Dietze S, Pahlitzsch T, Wennysia I, Persson P, Ludwig M . Short-term hypoxia and vasa recta function in kidney slices. Clin Hemorheol Microcirc. 2017; 67(3-4):475-484. DOI: 10.3233/CH-179230. View